Paul B. Manning, Director, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), bought 1,500,000 shares at $2.00 ($3.0M) on 2022-10-31, disclosed to the SEC on 2022-11-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| TSHA | BUY | 2025-06-03 | $2.1M | — | Filing → |